Background: Impaired fasting glucose (IFG) is a prediabetic condition and is a high-risk state for developing diabetes and associated complications. The aim of this study was to explore the association of vitamin D with insulin secretory function among the IFG subjects. Materials and Methods: This was a prospective cross-sectional study conducted in the Department of Biochemistry and Cell Biology, Bangladesh University of Health Sciences (BUHS), Dhaka, Bangladesh; from June 2016 to May 2017, on forty-six (46) IFG subjects. Serum blood glucose was measured by glucose-oxidase method, Fasting serum lipid profile (Total cholesterol, TG and HDL-c); liver enzyme like alanine aminotransferase (ALT) was measured by enzymatic-colorimetric method; Serum creatinine was measured by colorimetric kinetic method; Serum Insulin and vitamin D [25(OH)D] were measured by ELISA method; insulin secretory capacity (HOMA%B) and insulin sensitivity (HOMA%S) were calculated by Homeostasis Model Assessment (HOMA) using HOMA-CIGMA software. Results: Among 46 IFG subjects, 22 (47.8%) were male and rest 24 (52.2%) were female and their mean age was 40 (±8) years. Mean fasting serum glucose level of the study subjects was 6.33 (±0.23) mmol/l and mean postprandial serum glucose level was 7.23 (±0.41) mmol/l. Mean serum vitamin D level of the study subjects was 26.54 (±8.83) ng/ml. Mean HOMA%S, HOMA%B and HOMA%IR of the total study subjects were 48.34 (±16.70), 102.16 (±23.13) and 2.28 (±0.70) respectively. Insulin secretory capacity (HOMA%B) was significantly higher (p = 0.047) in the subjects having higher 
Introduction
Impaired fasting glucose (IFG) is the state of an individual whose fasting blood glucose levels are consistently elevated above normal but are not high enough to be considered as having diabetes mellitus. IFG is defined as elevated fasting plasma glucose (FPG) concentration ≥ 110 mg/dl and < 125 mg/dl (6.1 -6.9 mmol/L) [1] . Impaired fasting glucose (IFG) [Like impaired glucose tolerance (IGT)] is a prediabetic condition and is a high-risk state for developing diabetes and associated complications [2] . Globally 5% -10% people with prediabetes progress to diabetes each year [3] . Prediabetes is a common disorder in most populations. The reported prevalence of prediabetes appears to vary among populations with different ethnic backgrounds. Currently 314 million people are affected with prediabetes all over the world, and by 2025, it is estimated that approximately 500 million people will have prediabetes [4] .
In healthy people blood glucose is strictly regulated. Fasting glucose is maintained between 3.9 and 5.6 mmol/L and the post-meal increases rarely exceed 3 mmol/L. During the development of prediabetes, this homeostasis of fasting and post-load glucose becomes abnormal. Subjects with prediabetes manifest both core defects that are characteristic of type 2 diabetes i.e. insulin resistance and β-cell dysfunction. Study reveals that, IFG depends primarily on defective insulin secretion, and IGT on insulin resistance [5] . The first-phase insulin secretion decreases in subjects with IFG [6] [7] , whereas both first and second phases of insulin secretion are abnormal in those with IGT [8] . The pathophysiology of IFG seems to include the following key defects: reduced hepatic insulin sensitivity, stationary β-cell dysfunction and/or chronic low β-cell mass, altered glucagon-like peptide-1 secretion and inappropriately elevated glucagon secretion. The aetiology of IFG is predominantly related to genetic factors, smoking and male sex [9] .
Vitamin D is a fat soluble vitamin and is obtained from diet (oily fish or fortified dairy products), dietary supplements and sun exposure. Vitamin D is a multifunctional hormone that can affect many essential biological functions, ranging from immune regulation to mineral ion metabolism. Although the major function of vitamin D is to maintain calcium and phosphate homeostasis and to promote bone mineralization, many extraskeletal roles for vitamin D have been [10] . Recently it has been reported that vitamin D inadequacy is associated with significant coronary artery stenosis [11] . Some studies have shown that low vitamin D status is associated with an increased risk of various diseases, such as cancer, hypertension, and cardiovascular disease [10] . Vitamin D has been associated with the functioning and regulation of over 200 genes [12] . Vitamin D exerts its action in a variety of cell types through vitamin D receptor (VDR). Molecular evidence have documented that pancreatic β-cells express both cytolic/nuclear VDR, thus enhances β-cells function [13] . Additionally, vitamin D protects pancreatic β-cells from immune attack [14] . 
Materials and Methods
A prospective cross-sectional study has been conducted in the Department of 
Procedure

Recruitment of the Subjects
According to WHO criteria forty-six ( history, preliminary selection was done, and the purpose of the study was explained in details to each subject and their verbal consent was taken. They were advised to take unrestricted carbohydrate diet, to do normal physical activities and to avoid drugs and vitamin supplementations that significantly interfere blood glucose level (like glucocorticoids, oral contraceptives containing levonorgestrel or high-dose estrogen, phenytoin, high-dose thiazide diuretics, etc.) for 3 days. They were also advised to abandon the program if they became sick.
Then they were requested to report to BUHS Biochemistry laboratory after 3 days at morning between 8.00-10.00 am following an overnight (8 -12 hours) fasting. When the subjects reported, informed written consent was taken from all participants. A predesigned case record form was used to record relevant clinical, medical, demographic, socio-economic data (age, sex, educational sta- 
Sample Collection and Storage
Overnight fasting (8 -12 hours) blood was collected between 8.00-9.00 am.
Venous blood (6 ml) was obtained by venipuncture following standard procedure. Subjects were then allowed to drink glucose (75 gm in 300 ml of water).
Then they were requested not to take any food & beverage and be rested for two hours. After 2 hours of glucose intake the second blood sample (3.00 ml venous blood) was taken. Fasting and postprandial blood samples were taken into plain tube (6 cc), allowed to clot for 30 minutes and serum was separated by centrifugation for 10 min at 3000 rpm and then the serum was collected at least 600 µl in each of four aliquots. Blood samples were maintained at 4˚C until separation and serum was frozen at −30˚C within an hour of sample collection. One aliquot was assayed for fasting serum glucose, serum glucose 2 hours after 75 gm oral measurement respectively. The remaining aliquot was kept frozen at −30˚C for further measurement. Serum was not allowed to be thawed until the assay was performed.
Insulin secretory function (HOMA%B) and insulin sensitivity (HOMA%S) was calculated from fasting serum glucose and insulin values by Homeostasis
Model Assessment (HOMA) using HOMA-CIGMA software.
Analytical Methods
Biochemical measurements were carried out at the Biochemistry Lab, Dept of The following laboratory investigations were done for each of the study subject-• Serum blood glucose was measured by glucose-oxidase method in the automatic analyzer (Siemens Dimension-RXL, max, Siemens, USA).
• Fasting serum lipid profile (Total cholesterol, TG and HDL-c) and liver enzyme like Serum Alanine Aminotransferase (ALT) were measured by enzymatic-colorimetric method in the automatic analyzer (Siemens Dimension-RXL, max, Siemens, USA).
• Serum creatinine was measured by colorimetric kinetic method in the automatic analyzer (Siemens Dimension-RXL, max, Siemens, USA). 
Statistical Analysis
All the collected data were rechecked, coded and entered into a database using 
Results
Among forty-six (46) (Table 4) . (Table 5 ).
There was no significant difference in biochemical characteristics according to cut-off point [< 20 ng/ml of 25(OH)D levels and ≥20 ng/ml of 25(OH)D levels] among the total IFG subjects (Table 6 ). (Table 9) .
Multiple linear regression analysis was done by considering HOMA%B as dependent variable and BMI, TG and S. vitamin D as independent variables.
Where BMI had a positive association (p = 0.009) with HOMA%B but TG and S.
vitamin D showed no significant association with HOMA%B after adjusting the confounding variables (Table 10) .
Multiple linear regression analysis was done by considering HOMA%S as dependent variable and BMI, TG and S. vitamin D as independent variables.
Where BMI, TG and S. vitamin D showed no significant association with HOMA%S after adjusting the confounding variables (Table 11 ).
Discussion
Impaired fasting glucose (IFG) is a prediabetic condition and is a transitory state The level of significance at p < 0.05; r = correlation coefficient. level of our study subjects was 26.54 ± 8.83 ng/ml, which reflects the usual vitamin D status of our healthy population. This finding was consistent with study done on Asian population and they demonstrated that in South Asia, 80% of the apparently healthy population is deficient in vitamin D (<20 ng/ml) and up to 40% of the population is severely deficient (<9 ng/ml) [35] . In a recent study in [42] . Observational studies have reported an increased risk of vitamin D deficiency in those who are obese; however, the underlying explanations and direction of causality are unclear [43] . In the present study no such association was found between BMI and active vitamin D. As the IFG subjects in the present study were not obese but overweight (BMI = 27) the inverse association of vitamin D with BMI was not observed. 
Limitation
This was a cross sectional study with small sample size, thus our results cannot establish cause & effective relationship between vitamin D with insulin secretory function in impaired fasting glucose (IFG) subjects.
